Brief: Arch Therapeutics Announces Intent To Uplist From OTC To National Exchange
16/09/2022 11:50
Sept 16 (Reuters) - Arch Therapeutics Inc ARTH.PK :
* ARCH THERAPEUTICS ANNOUNCES INTENT TO UPLIST FROM OTC TO A
NATIONAL EXCHANGE
Source text for Eikon: ID:nGNX4KCMyN
Further company coverage: ARTH.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Arch Therapeutics
See all newsBrief: Arch Therapeutics Announces Intent To Uplist From OTC To National Exchange
Brief: Arch Therapeutics Raises Approximately $3.5 Million In Convertible Note Financing
Brief: Arch Raises About $1.1 Mln With Convertible Note Issuance
Brief: Arch Therapeutics Receives Marketing Clearance From The US FDA Related To The AC5 Topical Gel Supply Chain
Brief: Arch Therapeutics Withdraws 510(K) With Plans To Resubmit After Further Discussions With FDA